Immune Therapeutics Inc (OTCQB:IMUN)

During the Trading Day
0.0305 +0.0025 / +8.75%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.0296 -0.0009 / -2.96%
 
Volume: --
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.03
Today’s open0.03
Day’s range0.03 - 0.03
Volume1,705,100
Average volume (3 months)1,407,841
Market cap$10.7M
Data as of 3:59pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)-88.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.62%
P/E ratio--
Price/Sales3,128.62
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$3.5K
Annual profit (last year)-$19.5M
Net profit margin-563,713.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Noreen Griffin
Chief Operating Officer
Rudy J. Williams
Corporate headquarters
Orlando, Florida

Forecasts